When you think of Arduino projects, your mind likely goes straight to RFID door locks, weather sensors, or automated plant watering systems. While these are undeniably pretty cool projects, you might ...

Gesture control robotics replaces traditional buttons and joysticks with natural hand movements. This approach improves user interaction and reduces mechanical dependency on physical controllers.

New York, N.Y., Jan. 15, 2026 (GLOBE NEWSWIRE) -- NANO Nuclear Energy Inc. (NASDAQ: NNE) ("NANO Nuclear” or "the Company”), a leading advanced nuclear micro modular reactor (MMR) and technology ...

Nano Labs Ltd (NASDAQ: NA) is reshaping its capital strategy as it leans further into digital assets and shareholder returns amid a volatile year for the stock. The stock gained on Wednesday after it ...

GPS module for Yaesu VX-8DR/DE handheld transceivers with ublox NEO-6M chip and Arduino Nano by Dmitry Melnichansky 4Z7DTF (4X5DM since June 2016 4X1MD since July 24, 2017). When I was buying my Yaesu ...

A positively-charged dextran nano-photosensitizer (p-Dex PS) facilitates TAM-mediated delivery and sublethal light-induced metabolic reprogramming, which boost the TAM polarization and subsequently ...

HONG KONG, Nov. 26, 2025 (GLOBE NEWSWIRE) -- Nano Labs Ltd (Nasdaq: NA) ("we,” the "Company” or "Nano Labs”), a leading Web 3.0 infrastructure and product solution provider, today announced the launch ...

Milestone demonstrates NANO Nuclear's ability to bring advanced nuclear technology from initial design to construction and demonstration New York, New York--(Newsfile Corp. - July 23, 2025) - NANO ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

Embedded AI combines machine learning with edge devices for local, real-time intelligence. Courses range from beginner to advanced, covering TinyML, signal processing, and deployment. Ideal for ...

On Thursday, iBio, Inc. (NYSE:IBIO) expanded its cardiometabolic and obesity treatment development program by in-licensing a potentially long-acting anti-myostatin antibody from AstralBio, Inc. In ...